rs878854644
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PVS1PM2PP3PP5_Moderate
The NM_004260.4(RECQL4):c.1816G>T(p.Glu606*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000205 in 1,460,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. E606E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004260.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004260.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | NM_004260.4 | MANE Select | c.1816G>T | p.Glu606* | stop_gained | Exon 11 of 21 | NP_004251.4 | ||
| RECQL4 | NM_001413019.1 | c.1816G>T | p.Glu606* | stop_gained | Exon 11 of 20 | NP_001399948.1 | |||
| RECQL4 | NM_001413036.1 | c.1816G>T | p.Glu606* | stop_gained | Exon 11 of 21 | NP_001399965.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | ENST00000617875.6 | TSL:1 MANE Select | c.1816G>T | p.Glu606* | stop_gained | Exon 11 of 21 | ENSP00000482313.2 | ||
| RECQL4 | ENST00000621189.4 | TSL:1 | c.745G>T | p.Glu249* | stop_gained | Exon 10 of 20 | ENSP00000483145.1 | ||
| RECQL4 | ENST00000534626.6 | TSL:5 | c.184G>T | p.Glu62* | stop_gained | Exon 2 of 8 | ENSP00000477457.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460034Hom.: 0 Cov.: 36 AF XY: 0.00000275 AC XY: 2AN XY: 726294 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Baller-Gerold syndrome Pathogenic:1
Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This sequence change creates a premature translational stop signal (p.Glu606*) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 239708). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at